Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)
Titel:
Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)
Auteur:
Loibl, Sibylle de la Pena, Lorena Nekljudova, Valentina Zardavas, Dimitrios Michiels, Stefan Denkert, Carsten Rezai, Mahdi Bermejo, Begoña Untch, Michael Lee, Soo Chin Turri, Sabine Urban, Patrick Kümmel, Sherko Steger, Guenther Gombos, Andrea Lux, Michael Piccart, Martine J. Von Minckwitz, Gunter Baselga, José Loi, Sherene